Trading by management and close relations of management
September 12, 2024 05:31 ET
|
Novonesis (Novozymes A/S)
Please read the full announcement in PDF
Attachment
2024_36_Trading_By_Management
...
Trading by management and close relations of management
September 11, 2024 07:08 ET
|
Novonesis (Novozymes A/S)
Please read the full announcement in PDF
Attachment
2024_35_Trading_By_Management
...
Major shareholder announcement
September 10, 2024 06:33 ET
|
Novonesis (Novozymes A/S)
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Major shareholder announcement
September 06, 2024 02:51 ET
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Major shareholder announcement
September 05, 2024 07:07 ET
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Trading by management and close relations of management
September 02, 2024 12:36 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_31_Trading_By_Management
...
Trading by management and close relations of management
September 02, 2024 12:27 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_30_Trading_By_Management
...
Trading by management and close relations of management
August 30, 2024 06:17 ET
|
Novozymes A/S
Please read the full announcement in PDF
Attachment
2024_29_Trading_By_Management
...
Major shareholder announcement
August 29, 2024 09:17 ET
|
Novozymes A/S
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
Novonesis delivers strong half-year results and increases full-year outlook
August 27, 2024 10:34 ET
|
Novozymes A/S
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic...